
Peter Keeling of Diaceutics
In the Company of Mavericks
00:00
Diasutics and the DXRX Platform - What's the Scale?
Diasutics' DXRX platform is based on data from over 70,000 labs in 15 countries that are doing some type of cancer testing. The company believes it can drive the adoption of a new diagnostic in under 10 months. It's not diagnostic technology companies but hospitals and commercial labs sitting within our hospitals who need to be changed.
Transcript
Play full episode